News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

New osteoporosis treatment set to provide another option


5 July 2018

Media release

New osteoporosis treatment set to provide another option for patients

PHARMAC is pleased to provide another treatment option for patients with severe osteoporosis following the funding of denosumab, brand name Prolia, from 1 July 2018.

Osteoporosis is a condition that weakens the bones and increases the risk of fractures, and is common in people aged 50 years and over.

PHARMAC Director of Operations Lisa Williams says that denosumab will provide people with osteoporosis a chance of reducing injuries that can have a big impact on their daily lives.

“Osteoporosis is a serious illness that causes bone fractures and this can significantly affect the quality of life for people who have it,” says Ms Williams.

“The most significant injuries can be hip or vertebrae fractures. This can result in long recovery times, affecting the ability of people to live normal lives. Denosumab will reduce the chance of these serious injuries.

“Funding this treatment will not only help patients with osteoporosis, but also reduce the burden on carers as well. More than 3000 people over three years are expected to benefit from this funding decision.”

Denosumab will be available to eligible people who have severe osteoporosis, are unable to take zoledronic acid as a treatment, and have tried other funded treatments and still experienced a fracture.

“We’re pleased that people provided feedback during consultation asking for denosumab to be extended to men as well,” says Ms Williams. “We were able to take that feedback to our clinical advisers who said that men would experience the same benefit as women, and we amended our funding criteria as a result.”

People with osteoporosis should talk to their health professional to see if denosumab is suitable for them.

More information can be found on funding notification listed on the PHARMAC website.

ends

© Scoop Media

 
 
 
Culture Headlines | Health Headlines | Education Headlines

 

Howard Davis: Charlotte Yates' Mansfield Project

Katherine Mansfield's vapid verses are of even less interest than her over-rated short stories, but Yates has risen to the challenge of producing a fascinating compilation album by a variety of musicians to accompany her poetry. More>>

Howard Davis: Dazed & Confused by Beats

Beats is both a coming-of-age tale and a romantic movie about endings, set to a nostalgic backdrop of the disappearing tail of the UK's illegal rave scene. More>>

Howard Davis: And The Oscar Goes To … Parasite
For its deliciously dark wit and genre-bending ingenuity, Bong Joon-ho's latest movie has just won four out of a potential six Academy Awards, including Best Screenplay and Director. Only ten foreign-language films have previously been nominated for Best Picture and none have won before. More>>

Howard Davis: 1917's 1,000 Yard Stare

Sam Mendes has created a terrible and barbarous trek, one that we appreciate all the more for being catapulted right into the midst of this ear-splitting melee from the film's opening sequence. More>>

Howard Davis: 1917's 1,000 Yard Stare

Sam Mendes has created a terrible and barbarous trek, one that we appreciate all the more for being catapulted right into the midst of this ear-splitting melee from the film's opening sequence. More>>

Over 150 Productions: NZ Fringe 2020 Has Launched

The upcoming festival will be held at 40 venues all over Wellington Region from 28 February to 21 March, and includes every genre possible—theatre, comedy, dance, music, clowning, cabaret, visual art, children’s shows and more! More>>

ALSO:

 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION
 


 
  • Wellington
  • Christchurch
  • Auckland